Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioInvent International AB: BioStock: BioInvent achieves research milestone in partnership with Exelixis

BioInvent International

BioInvent has achieved a research milestone in its partnership with Exelixis, focusing on the development of new antibodies for cancer therapy. This achievement unlocks a 1 million USD payment to BioInvent. The company's CEO Martin Welschof expressed satisfaction with the rapid progress of the collaboration while noting that it also serves as further validation for BioInvent's proprietary F.I.R.S.T. and n-CoDeR technologies.

Read the article at biostock.se:

https://www.biostock.se/en/2023/09/bioinvent-achieves-research-milestone-in-partnership-with-exelixis/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.